Simon Olivares

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.

Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing.

Amplification of RNAi--targeting HLA mRNAs.

A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells.

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.

Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.

A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.

Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.

Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor.